Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancer

被引:25
作者
Park, Yae Won [1 ,2 ,3 ]
An, Chansik [4 ]
Lee, JaeSeong [5 ]
Han, Kyunghwa [1 ,2 ,3 ]
Choi, Dongmin [6 ]
Ahn, Sung Soo [1 ,2 ,3 ]
Kim, Hwiyoung [1 ,2 ,3 ]
Ahn, Sung Jun [7 ]
Chang, Jong Hee [8 ]
Kim, Se Hoon [9 ]
Lee, Seung-Koo [1 ,2 ,3 ]
机构
[1] Yonsei Univ, Coll Med, Dept Radiol, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Coll Med, Res Inst Radiol Sci, 50-1 Yonsei Ro, Seoul 03722, South Korea
[3] Yonsei Univ, Coll Med, Ctr Clin Imaging Data Sci, 50-1 Yonsei Ro, Seoul 03722, South Korea
[4] Natl Hlth Insurance Serv Ilsan Hosp, Res & Anal Team, Goyang, South Korea
[5] Yonsei Univ, Dept Mech Engn, Seoul, South Korea
[6] Yonsei Univ, Dept Comp Sci, Seoul, South Korea
[7] Yonsei Univ, Gangnam Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea
[8] Yonsei Univ, Dept Neurosurg, Coll Med, Seoul, South Korea
[9] Yonsei Univ, Dept Pathol, Coll Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Epidermal growth factor receptor; Imaging; Diffusion tensor; Machine learning; Magnetic resonance imaging; Radiomics; TUMORS; FEATURES; PROGRESSION; DIAGNOSIS; SURVIVAL; TEXTURE; LESIONS; GENE;
D O I
10.1007/s00234-020-02529-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose To assess whether the radiomic features of diffusion tensor imaging (DTI) and conventional postcontrast T1-weighted (T1C) images can differentiate the epidermal growth factor receptor (EGFR) mutation status in brain metastases from non-small cell lung cancer (NSCLC). Methods A total of 99 brain metastases in 51 patients who underwent surgery or biopsy with underlying NSCLC and known EGFR mutation statuses (57 from EGFR wild type, 42 from EGFR mutant) were allocated to the training (57 lesions in 31 patients) and test (42 lesions in 20 patients) sets. Radiomic features (n= 526) were extracted from preoperative MR images including T1C and DTI. Radiomics classifiers were constructed by combinations of five feature selectors and four machine learning algorithms. The trained classifiers were validated on the test set, and the classifier performance was assessed by determining the area under the curve (AUC). Results EGFR mutation status showed an overall discordance rate of 12% between the primary tumors and corresponding brain metastases. The best performing classifier was a combination of the tree-based feature selection and linear discriminant algorithm and 5 features were selected (1 from ADC, 2 from fractional anisotropy, and 2 from T1C images), resulting in an AUC, accuracy, sensitivity, and specificity of 0.73, 78.6%, 81.3%, and 76.9% in the test set, respectively. Conclusions Radiomics classifiers integrating multiparametric MRI parameters may have potential in differentiating the EGFR mutation status in brain metastases from NSCLC.
引用
收藏
页码:343 / 352
页数:10
相关论文
共 50 条
  • [21] Development and Validation of Machine Learning Models to Predict Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer: A Multi-Center Retrospective Radiomics Study
    Liu, Yafeng
    Zhou, Jiawei
    Wu, Jing
    Wang, Wenyang
    Wang, Xueqin
    Guo, Jianqiang
    Wang, Qingsen
    Zhang, Xin
    Li, Danting
    Xie, Jun
    Ding, Xuansheng
    Xing, Yingru
    Hu, Dong
    CANCER CONTROL, 2022, 29
  • [22] Epidermal growth factor receptor status and Notch inhibition in non-small cell lung cancer cells
    Efstathia Giannopoulou
    Achilleas Nikolakopoulos
    Dimitra Kotsirilou
    Angeliki Lampropoulou
    Sofia Raftopoulou
    Evangelia Papadimitriou
    Achilleas D. Theocharis
    Thomas Makatsoris
    Konstantinos Fasseas
    Haralabos P. Kalofonos
    Journal of Biomedical Science, 22
  • [23] Targeting the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer
    Steins, Martin B.
    Reinmuth, Niels
    Bischoff, Helge
    Kindermann, Markus
    Thomas, Michael
    ONKOLOGIE, 2010, 33 (12): : 704 - 709
  • [24] Epidermal growth factor receptor status and Notch inhibition in non-small cell lung cancer cells
    Giannopoulou, Efstathia
    Nikolakopoulos, Achilleas
    Kotsirilou, Dimitra
    Lampropoulou, Angeliki
    Raftopoulou, Sofia
    Papadimitriou, Evangelia
    Theocharis, Achilleas D.
    Makatsoris, Thomas
    Fasseas, Konstantinos
    Kalofonos, Haralabos P.
    JOURNAL OF BIOMEDICAL SCIENCE, 2015, 22
  • [25] Clinicopathologic features of non-small cell lung cancer in India and correlation with epidermal growth factor receptor mutational status
    Bhatt, A. D.
    Pai, R.
    Rebekah, G.
    Nehru, Arun G.
    Dhananjayan, S.
    Samuel, A.
    Singh, A.
    Joel, A.
    Korula, A.
    Chacko, R. T.
    INDIAN JOURNAL OF CANCER, 2013, 50 (02) : 94 - 101
  • [26] Differential Distribution of Brain Metastases from Non-Small Cell Lung Cancer Based on Mutation Status
    Chen, Bihong T. T.
    Jin, Taihao
    Ye, Ningrong
    Chen, Sean W. W.
    Rockne, Russell C.
    Yoon, Stephanie
    Mambetsariev, Isa
    Daniel, Ebenezer
    Salgia, Ravi
    BRAIN SCIENCES, 2023, 13 (07)
  • [27] Management of Brain Metastases in epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer
    Kelly, William J.
    Shah, Neil J.
    Subramaniam, Deepa S.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [28] Frequency and significance of epidermal growth factor receptor mutations detected by PCR methods in patients with non-small cell lung cancer
    Nakajima, Eiji
    Sugita, Michio
    Furukawa, Kinya
    Takahashi, Hidenobu
    Uchida, Osamu
    Kawaguchi, Youhei
    Ohira, Tatsuo
    Matsubayashi, Jun
    Ikeda, Norihiko
    Hirsch, Fred R.
    Franklin, Wilbur A.
    ONCOLOGY LETTERS, 2019, 17 (06) : 5125 - 5131
  • [29] Rad51 in regulating the radiosensitivity of non-small cell lung cancer with different epidermal growth factor receptor mutation status
    Zhong, Xing
    Luo, Guomin
    Zhou, Xiaojuan
    Luo, Wen
    Wu, Xia
    Zhong, Renming
    Wang, Yanping
    Xu, Feng
    Wang, Jin
    THORACIC CANCER, 2016, 7 (01) : 50 - 60
  • [30] Complex Mutation of Epidermal Growth Factor Receptor (EGFR) in Patients with Non-Small Lung Cancer
    Arai, Hiromasa
    Tajiri, Michihiko
    Morita, Junya
    Kameda, Yohei
    Shiino, Kimihisa
    Okudela, Koji
    Masuda, Munetaka
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S497 - S498